Compile Data Set for Download or QSAR
Report error Found 2076 of affinity data for UniProtKB/TrEMBL: Q16853
TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 561951BDBM561951(US11396495, No. 6 | 6-[(Z)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.0400nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 561952BDBM561952(US11396495, No. 7 | 6-[(E)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.0900nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 561958BDBM561958(US11396495, No. 13 | ethyl 2-[6-[(Z)-2-(aminomethy...)
Affinity DataIC50: 0.110nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 561957BDBM561957(US11396495, No. 12 | ethyl 2-[6-[(E)-2-(aminomethy...)
Affinity DataIC50: 0.140nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581433BDBM581433(US11505532, Compound WX103)
Affinity DataIC50: 0.200nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581415BDBM581415(US11505532, Compound WX085)
Affinity DataIC50: 0.200nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581448BDBM581448(US11505532, Compound WX126)
Affinity DataIC50: 0.200nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497208BDBM497208(US11001563, Compound WX103)
Affinity DataIC50: 0.200nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581410BDBM581410(US11505532, Compound WX079)
Affinity DataIC50: 0.200nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497223BDBM497223(US11001563, Compound WX126)
Affinity DataIC50: 0.200nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497190BDBM497190(US11001563, Compound WX085)
Affinity DataIC50: 0.200nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497185BDBM497185(US11001563, Compound WX079)
Affinity DataIC50: 0.200nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 561955BDBM561955(US11396495, No. 10 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.220nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 561959BDBM561959(US11396495, No. 16 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.220nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581434BDBM581434(US11505532, Compound WX104)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497209BDBM497209(US11001563, Compound WX104)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581413BDBM581413(US11505532, Compound WX082)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497172BDBM497172(US11001563, Compound WX049)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581382BDBM581382(US11505532, Compound WX024)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581379BDBM581379(US11505532, Compound WX021)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581380BDBM581380(US11505532, Compound WX022)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581417BDBM581417(US11505532, Compound WX087)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581386BDBM581386(US11505532, Compound WX033)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497199BDBM497199(US11001563, Compound WX094)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497198BDBM497198(US11001563, Compound WX093)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581384BDBM581384(US11505532, Compound WX026)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497161BDBM497161(US11001563, Compound WX033)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497192BDBM497192(US11001563, Compound WX087)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497159BDBM497159(US11001563, Compound WX026)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581423BDBM581423(US11505532, Compound WX093)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581424BDBM581424(US11505532, Compound WX094)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497157BDBM497157(US11001563, Compound WX024)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581397BDBM581397(US11505532, Compound WX049)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497188BDBM497188(US11001563, Compound WX082)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497155BDBM497155(US11001563, Compound WX022)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497154BDBM497154(US11001563, Compound WX021)
Affinity DataIC50: 0.300nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 561953BDBM561953(US11396495, No. 8 | 6-[(E)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.320nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 561950BDBM561950(US11396495, No. 5 | 6-[(E)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.370nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581399BDBM581399(US11505532, Compound WX054)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581431BDBM581431(US11505532, Compound WX101)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497214BDBM497214(US11001563, Compound WX111)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581432BDBM581432(US11505532, Compound WX102)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581373BDBM581373(US11505532, Compound WX008)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497148BDBM497148(US11001563, Compound WX008)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497207BDBM497207(US11001563, Compound WX102)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581439BDBM581439(US11505532, Compound WX111)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497174BDBM497174(US11001563, Compound WX054)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 497206BDBM497206(US11001563, Compound WX101)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the gra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581381BDBM581381(US11505532, Compound WX023)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 581414BDBM581414(US11505532, Compound WX083)
Affinity DataIC50: 0.400nMAssay Description:The inhibition of the sample on VAP-1 enzyme activity was measured by using an Amplex Red Monoamine Oxidase kit (Invitrogen #A12214). 100 nL of the g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2023
Entry Details
US Patent

Displayed 1 to 50 (of 2076 total ) | Next | Last >>
Jump to: